Stock Events

Sangamo Therapeutics (0R1D.LSE) Q2 2024 Earnings

9MayConfirmed
Q2 2024
-0.27
-0.25
-0.23
-0.21

Details

Expected EPS
-0.21375
Actual EPS
-0.27
Surprise EPS
-0.06
Surprise Percent
+26.32%

Description

Sangamo Therapeutics (0R1D.LSE) has reported earnings of -0.27 per share for Q2 2024.

0 Comments

Share your thoughts